CRISPR Gene Editing Shows Promise: Early Trial Improves Vision in Blind Children
Gene therapy has shown promise in improving eyesight in congenitally blind children with Leber Congenital Amaurosis (LCA), a rare disease.
Source: techtimes.com
Stay updated with breaking news from Tomas Aleman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gene therapy has shown promise in improving eyesight in congenitally blind children with Leber Congenital Amaurosis (LCA), a rare disease.
Key Takeaways
An injectable gene therapy caused measurable improvements in vision among a small group of people with inherited blindness, an early-stage clinical trial says.
(CTN News) - CRISPR/Cas9 gene editing therapy has shown measurable improvement in 79 percent of patients with a rare form of.................